Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817089 · ClinicalTrials.gov registry record · Phase 4
Understanding Treatment Response With Naltrexone Among White Alcoholics
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00817089: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT00817089 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00817089, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a study involving treatment for alcohol dependence among males of European or Asian decent. The ultimate aim of this line of investigation is to further establish a genetic link between alcohol dependence and treatment by defining an endophenotype associated with treatment response. The study consists of two inpatient alcohol challenge sessions with treatment using random assignment to either naltrexone or placebo.
Interventions
- DRUG Placebo Oral Tablet
- DRUG Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00817089
The ClinicalTrials.gov registry entry for NCT00817089 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT00817089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00817089 about?
NCT00817089 is a clinical study titled "Understanding Treatment Response With Naltrexone Among White Alcoholics". This is a study involving treatment for alcohol dependence among males of European or Asian decent. The ultimate aim of this line of investigation is to further establish a genetic link between alcohol dependence and treatment by defining an endophenotype associated with treatment response. The stud...
What is the current status of trial NCT00817089?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2007-12. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00817089?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00817089?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.